Both the experimental and control groups showed significant improvement in prostatitis symptoms and sexual function after treatment as compared with the baseline ( P < 0.01 ) , even more significant in the former than in the latter group , especially in pain symptoms ( 7.89 + / - 2.82 vs 10.41 + / - 2.55 , P < 0.01 ) .